E Fund Management Hong Kong Co. Ltd. Boosts Stake in Axon Enterprise, Inc $AXON

E Fund Management Hong Kong Co. Ltd. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 508.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,757 shares of the biotechnology company’s stock after purchasing an additional 1,468 shares during the period. E Fund Management Hong Kong Co. Ltd.’s holdings in Axon Enterprise were worth $985,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Rockefeller Capital Management L.P. raised its stake in shares of Axon Enterprise by 53.2% in the 4th quarter. Rockefeller Capital Management L.P. now owns 11,518 shares of the biotechnology company’s stock valued at $6,542,000 after acquiring an additional 4,002 shares during the period. Legal & General Group Plc boosted its position in shares of Axon Enterprise by 1.3% during the 4th quarter. Legal & General Group Plc now owns 426,533 shares of the biotechnology company’s stock worth $242,241,000 after purchasing an additional 5,419 shares during the period. Eurizon Capital SGR S.p.A. purchased a new position in shares of Axon Enterprise during the 4th quarter worth approximately $13,116,000. Arrowstreet Capital Limited Partnership acquired a new stake in Axon Enterprise in the 1st quarter valued at approximately $15,067,000. Finally, Harel Insurance Investments & Financial Services Ltd. increased its holdings in Axon Enterprise by 40.7% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 15,083 shares of the biotechnology company’s stock valued at $6,406,000 after purchasing an additional 4,360 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Axon Enterprise news, CRO Cameron Brooks sold 1,242 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total value of $621,000.00. Following the sale, the executive owned 49,710 shares of the company’s stock, valued at $24,855,000. This trade represents a 2.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $10,000,000.00. Following the completion of the transaction, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. The trade was a 0.65% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 68,989 shares of company stock worth $36,016,932 over the last three months. Company insiders own 4.20% of the company’s stock.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Strong Q2 results and raised outlook: Axon exceeded expectations with adjusted earnings of $1.88 per share versus $1.84 expected and revenue of $904.4 million versus $876.4 million expected. Revenue grew 35.3% year over year, and management’s improved outlook supports the long-term growth story. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
• Positive Sentiment: Connected Devices momentum: TASER devices, body cameras and counter-drone products are driving strong hardware demand. Continued adoption of these products, combined with Axon’s cloud-based evidence and records software, reinforces the company’s integrated platform strategy. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
• Positive Sentiment: Bullish strategic commentary: Analysts highlighted Axon as a strong contender in law-enforcement technology, while coverage pointed to new artificial-intelligence capabilities as an additional growth catalyst for public-safety customers. Axon: A Strong Contender in Law Enforcement Tech
• Neutral Sentiment: Technical consolidation: AXON remains in a strong broader uptrend but has recently consolidated, leaving investors watching whether momentum resumes or the rally pauses. Stock of the Day: Is the Axon Rally Over?
• Negative Sentiment: Valuation and profitability risks: Despite strong revenue growth, analysts cautioned that Axon’s high earnings multiple, elevated costs, debt and relatively modest margins reduce its near-term appeal. Memory costs and counter-drone investments could also pressure profitability if spending rises faster than sales.
• Negative Sentiment: CEO share sale: CEO Patrick Smith sold 9,930 shares worth approximately $5.45 million. The transaction occurred under a pre-arranged Rule 10b5-1 plan and represented only 0.33% of his holdings, making it a limited signal but a potential source of investor caution.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $615.59 on Friday. The firm has a 50 day moving average of $523.52 and a two-hundred day moving average of $473.43. The stock has a market capitalization of $50.01 billion, a PE ratio of 255.43, a P/E/G ratio of 12.24 and a beta of 1.39. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $794.29.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company’s revenue was up 35.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.12 earnings per share. On average, research analysts predict that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on AXON shares. Citizens Jmp restated a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a research note on Thursday, June 25th. Needham & Company LLC restated a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. Finally, Morgan Stanley increased their target price on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $730.92.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.